Patents by Inventor Chris VIAU

Chris VIAU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PEPTIDOMIMETIC MACROCYCLES AND USES THEREOF
    Publication number: 20230106577
    Abstract: Methods for treating a solid tumor, determined to lack a p53 deactivation mutation, in a subject are provided. Also provided are peptidomimetic macrocycles for use in treatment of a solid tumor, determined to lack a p53 deactivation mutation, in a subject.
    Type: Application
    Filed: June 21, 2022
    Publication date: April 6, 2023
    Inventors: Hubert CHEN, David Allen ANNIS, Yong CHANG, Manuel AIVADO, Karen OLSON, Chris VIAU
  • PEPTIDOMIMETIC MACROCYCLES AND USES THEREOF
    Publication number: 20200085908
    Abstract: Methods for treating solid tumor, determined to lack a p53 deactivation mutation, in a subject are provided. Also provided are peptidomimetic macrocycles for use in treatment of a solid tumor, determined to lack a p53 deactivation mutation, in a subject.
    Type: Application
    Filed: September 6, 2019
    Publication date: March 19, 2020
    Inventors: Hubert CHEN, David Allen ANNIS, Yong CHANG, Manuel AIVADO, Karen OLSON, Chris VIAU
  • PEPTIDOMIMETIC MACROCYCLES AND USES THEREOF
    Publication number: 20190269753
    Abstract: Methods for treating solid tumor, determined to lack a p53 deactivation mutation, in a subject are provided. Also provided are peptidomimetic macrocycles for use in treatment of a solid tumor, determined to lack a p53 deactivation mutation, in a subject.
    Type: Application
    Filed: March 15, 2019
    Publication date: September 5, 2019
    Inventors: Hubert Chen, David Allen Annis, Yong Chang, Manuel Aivado, Karen Olson, Chris Viau
  • PEPTIDOMIMETIC MACROCYCLES AND USES THEREOF
    Publication number: 20190256559
    Abstract: Methods for treating liquid cancer, determined to lack a p53 deactivation mutation, in a subject are provided. Also provided are peptidomimetic macrocycles for use in treatment of a liquid cancer, determined to lack a p53 deactivation mutation, in a subject.
    Type: Application
    Filed: December 18, 2018
    Publication date: August 22, 2019
    Inventors: Hubert Chen, David Allen Annis, Yong Chang, Manuel Aivado, Karen Olson, Chris Viau
  • Peptidomimetic macrocycles and uses thereof
    Patent number: 10253067
    Abstract: Methods for treating liquid cancer, determined to lack a p53 deactivation mutation, in a subject are provided. Also provided are peptidomimetic macrocycles for use in treatment of a liquid cancer, determined to lack a p53 deactivation mutation, in a subject.
    Type: Grant
    Filed: March 18, 2016
    Date of Patent: April 9, 2019
    Assignee: Aileron Therapeutics, Inc.
    Inventors: Hubert Chen, David Allen Annis, Yong Chang, Manuel Aivado, Karen Olson, Chris Viau
  • PEPTIDOMIMETIC MACROCYCLES AND USES THEREOF
    Publication number: 20160333049
    Abstract: Methods for treating liquid cancer, determined to lack a p53 deactivation mutation, in a subject are provided. Also provided are peptidomimetic macrocycles for use in treatment of a liquid cancer, determined to lack a p53 deactivation mutation, in a subject.
    Type: Application
    Filed: March 18, 2016
    Publication date: November 17, 2016
    Inventors: Hubert CHEN, David Allen ANNIS, Yong CHANG, Manuel AIVADO, kAREN OLSON, Chris VIAU